Answers are grounded in this paper and cite their sources.
Blocking flu: A cyclic peptide, cyclo(Ser-Gly-Gly-Gln-Ser-His-Asp)3, is an excellent scaffold for the synthesis of a cyclic glycopeptide carrying GM3 oligosaccharides with a potent inhibitory effect on the hemagglutination induced by the influenza virus. Tridentate binding of the gylcopeptide is shown to produce a much greater inhibitory effect than di- or monodentate binding. The shape of the glycopeptide protein scaffold, which is determined by the amino acid sequence employed, is also found to be significant in determining the inhibitory activity.
No takes yet. Share an insight, caveat, or question.
Ohta et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: